Madu tualang' honey as prophylaxis against febrile neutropenia in patients with haematological malignancy

This study is looking at whether a traditional honey product called 'Madu Tualang' can help prevent dangerous infections in people with blood cancer who are receiving chemotherapy. Chemotherapy can severely reduce white blood cell counts, leaving patients very vulnerable to infection. Researchers want to find out if taking honey alongside a standard antibiotic (ciprofloxacin) can further protect patients by reducing bacteria in the gut and protecting the gut lining. You may be eligible if: - You have a confirmed diagnosis of blood cancer (haematological malignancy) - You are planning to receive at least 2 cycles of the same chemotherapy regimen - Your functional status (ECOG score) is 3 or better - You are 12 years or older - You have signed the consent form You may NOT be eligible if: - You have a known allergy to ciprofloxacin - You have a known allergy to honey products - You are having high-dose chemotherapy for a stem cell transplant - You have severe diabetes requiring intravenous insulin - You are pregnant or breastfeeding - You already have an active infection requiring antibiotics - You have severe kidney or liver disease Talk to your doctor about whether this trial might be right for you.